ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report) shares crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $9.39 and traded as low as $8.25. ZIVO Bioscience shares last traded at $8.2507, with a volume of 3,975 shares traded.
ZIVO Bioscience Stock Performance
The company’s 50-day moving average is $9.39 and its 200 day moving average is $10.75. The company has a market capitalization of $33.02 million, a PE ratio of -1.69 and a beta of 0.23.
About ZIVO Bioscience
ZIVO Bioscience is a clinical-stage biotechnology company focused on developing precision live biotherapeutics to prevent and treat gastrointestinal infections in both animal and human health markets. The company applies synthetic biology, microbiology and fermentation technologies to engineer proprietary bacterial strains that produce targeted lactic acid and antimicrobial compounds. Its pipeline includes ZB-01, an orally administered therapy for recurrent Clostridioides difficile infections in humans, and ZB-02, a feed-additive candidate aimed at reducing Salmonella colonization in poultry.
Founded in 2016 and headquartered in Carlsbad, California, ZIVO Bioscience leverages exclusive licensing agreements with academic institutions to advance its lead programs through preclinical and early clinical development.
Read More
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
